HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,557-2,568 of 4,505
Drug study icon
CompletedNCT01104792

Long-term Study of Cariprazine in people with Schizophrenia

What is this study about?

This study evaluated the long-term safety of Cariprazine for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–60
Countries
United States, Colombia, India, + 3 others
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT00790192

Lurasidone HCL - A 6-week Phase 3 Study of people with Acute Schizophrenia.

What is this study about?

Researchers compared Lurasidone, Quetiapine XR and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–75
Countries
United States, India, Romania, + 2 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00789698

Lurasidone HCl - A Long Term Phase 3 Study of people with Chronic Schizophrenia

What is this study about?

Researchers compared Lurasidone HC1 and Quetiapine XR to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–75
Countries
United States, Colombia, India, + 3 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00615433

Lurasidone HCl A Phase 3 Study of people with Acute Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of Lurasidone for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–75
Countries
United States, Colombia, India, + 2 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT01821378

Lurasidone Low-Dose - High-Dose Study Study

What is this study about?

This study evaluated the safety and effectiveness of Lurasidone for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–75
Countries
United States, Colombia, Romania, + 3 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT03304457

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

Official study title

Effect of Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in First Episode Untreated Schizophrenia: A Randomized, Open Label, Active Controlled Study

This study has finished and is no longer accepting participants.

In Bhubaneswar
SchizophreniaMedication studyAges 18–45
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Drug study icon
CompletedNCT03376763

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

What is this study about?

Researchers studied Abilify maintena to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Gongju
SchizophreniaMedication studyAges 19–64
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Other study type icon
CompletedNCT00350805

Measuring Time Windows in people with Schizophrenia and Healthy Controls

Official study title

Relating the 'Experienced Present' With the Mechanisms of Neuronal Function: A Comparative Study in Patients With Schizophrenia and Healthy Controls Using Psychophysical and Neurophysiological Methods

This study has finished and is no longer accepting participants.

Multiple locations, including Créteil
SchizophreniaObservational studyAges 18–50
Countries
France
Sponsor
University Hospital, Strasbourg, France
Drug study icon
CompletedNCT01391390

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Official study title

The Effect of Melatonin Treatment on Tardive Dyskinesia and Oxidative Stress: A Double-Blind Placebo-Controlled Trial

This study has finished and is no longer accepting participants.

In Beijing
SchizophreniaMedication studyAges 18–70
Countries
China
Sponsor
Beijing HuiLongGuan Hospital
Drug study icon
CompletedNCT00757978

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

Official study title

Phase 4 Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms in Patients Using Clozapine. A Randomized, Double-Blind, Placebo Controled Study

This study has finished and is no longer accepting participants.

In Porto Alegre
SchizophreniaMedication studyAges 18–60
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.